Patent · US Active

Cationic materials and formulations for drug delivery

US11850309B2 · kind B2 · utility

6Cited by
5References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 24, 2020
Grant dateDec 26, 2023
Priority date
Expiry dateNov 14, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC08G81/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Cationic polymers are provided for delivering anionic active agents, preferably in the form or nanoparticles and other nanostructures. The polymer can be a polycation homopolymer or a copolymer containing a polycation block. The polycations and polycation containing polymers can contain dicarboxylic acid ester units and units of (α-amino acid)-α,ω-alkylene diester units. The nanoparticles can contain high loadings of anionic active agents, with sustained release of the active agents. Methods of making the polycations and polycation containing polymers are provided. Methods of making the nanoparticles and formulating them for administration to an individual in need thereof are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.